盆底重建术治疗盆腔器官脱垂的术后短期疗效观察

目的:探讨盆底重建术对于盆腔器官脱垂患者治疗术后短期疗效。方法:选取按(POP-Q)分度为Ⅲ～Ⅳ度的盆腔器官脱垂患者42例,随机分为两组各21例。对照组患者采取阴式子宫切除联合阴道壁修补术;观察组患者采取盆底重建术。对两组患者手术时间、术中出血量、保留尿管时间、平均住院时间、阴道长度、治愈率、复发率以及性生活满意率进行比较。术后3、6、9、12个月定期随访。结果:两组患者手术时间、术中出血量差别不大,无统计学差异(P>0.05)。观察组患者保留尿管时间以及平均住院时间均明显少于对照组;观察组患者阴道长度明显长于对照组,治愈率和性生活满意率明显高于对照组,而复发率则明显低于对照组。上述比较两组患者差别明显,有统计学意义(P<0.05)。结论:盆底重建术用以治疗盆腔器官脱垂损伤相对较小,可以取得良好的短期疗效,在临床中有着积极意义。

Observation of the short-term efficacy after surgery for pelvic floor reconstruction in the treatment of pelvic organ prolapse

Objective:To investigate the short-term efficacy after surgery for pelvic floor reconstruction in the treatment of pelvic organ prolapse.Methods:42 cases of Ⅲ ~ Ⅳ degree indexing(POP-Q) in patients with pelvic organ prolapse were randomly divided into two groups,and 21 cases were in each group.Patients in the control group were taken with vaginal hysterectomy joint vaginal wall repair and patients in observation group were taken with the pelvic floor reconstruction.The operative time,blood loss,and retained catheter time,the average length of stay,vaginal length,the cure rate,relapse rate,and sex life satisfaction rate were taken for comparison.Regular follow-up of 3,6,9 and 12 months after surgery was taken.Results:The operative time,blood loss was not very different,and there was no significant difference(P>0.05).The catheter time and the average length of stay in the observation group were significantly less than those of control group.The vaginal length in the observation group was significantly longer than that of control group.The cure rate and sexual satisfaction rate in the observation group were significantly higher than those of control group.The relapse rate was significantly lower than that of control group.There were statistical significance in the above indexes between the two groups(P<0.05).Conclusion:The damage for pelvic floor reconstruction surgery in the treatment of pelvic organ prolapsed is relatively small,it can achieve a good short-term efficacy,and it has a positive significance in the clinical application.